KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Gains from Sales and Divestitures (2016 - 2021)

Abbott Laboratories (ABT) has disclosed Gains from Sales and Divestitures for 12 consecutive years, with $6.5 million as the latest value for Q4 2021.

  • Quarterly Gains from Sales and Divestitures fell 9.21% to $6.5 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $6.5 million through Dec 2021, down 9.21% year-over-year, with the annual reading at $6.5 million for FY2021, 9.21% down from the prior year.
  • Gains from Sales and Divestitures hit $6.5 million in Q4 2021 for Abbott Laboratories, down from $7.2 million in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $7.8 million in Q4 2019 to a low of $6.5 million in Q4 2021.
  • Historically, Gains from Sales and Divestitures has averaged $7.3 million across 5 years, with a median of $7.5 million in 2018.
  • Biggest five-year swings in Gains from Sales and Divestitures: increased 29.29% in 2017 and later decreased 9.21% in 2021.
  • Year by year, Gains from Sales and Divestitures stood at $7.6 million in 2017, then fell by 0.42% to $7.5 million in 2018, then rose by 3.03% to $7.8 million in 2019, then decreased by 7.52% to $7.2 million in 2020, then decreased by 9.21% to $6.5 million in 2021.
  • Business Quant data shows Gains from Sales and Divestitures for ABT at $6.5 million in Q4 2021, $7.2 million in Q4 2020, and $7.8 million in Q4 2019.